via CCSVI in Multiple Sclerosis - "While the large pharmaceutical industry continues to spawn drugs based on the fairy tale that MS is an autoimmune disease, Dr. David Hubbard, of the Hubbard Foundation, continues to negotiate with the FDA to do a trial on CCSVI treatment.

The waiting process is interminable. We would like to thank Dr. Hubbard for his steadfastness and willingness to question the current drugs and their usefulness with Multiple Sclerosis, and his desire to help patients find the answers about CCSVI treatment.

Here is the most recent letter stalling trials of CCSVI that the Hubbard Foundation has received from the FDA." https://www.facebook.com/permalink.php?story_fbid=10151956689742298&id=110796282297


FDA Disapproval Response 10-18-13.pdf
www.dropbox.com
Shared with Dropbox